Anocca has submitted its first clinical trial application (CTA) for conducting the Phase I/II VIDAR-1 trial to the EMA.
Medically reviewed by Elizabeth Barnes, RDN Isoleucine is one of the three branched-chain amino acids (BCAAs). It is ...